• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU.单次及重复给予卡莫司汀(BCNU)和洛莫司汀(HECNU)后小鼠骨髓中DNA损伤与干细胞抑制之间的关系
J Cancer Res Clin Oncol. 1985;110(3):185-90. doi: 10.1007/BF00399271.
2
The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.在接受四种氯乙基亚硝基脲治疗的小鼠中,骨髓中DNA链间交联的水平与骨髓抑制的程度平行。
J Cancer Res Clin Oncol. 1984;108(1):141-7. doi: 10.1007/BF00390986.
3
Comparison of DNA damage in various tissues, myelosuppression and serum levels of transaminases and bilirubin in tumor-bearing female Sprague-Dawley rats treated with 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea (HECNU).用1-(2-羟乙基)-3-(2-氯乙基)-3-亚硝基脲(HECNU)处理的荷瘤雌性Sprague-Dawley大鼠不同组织中的DNA损伤、骨髓抑制以及转氨酶和胆红素血清水平的比较
J Cancer Res Clin Oncol. 1986;111(1):75-8. doi: 10.1007/BF00402781.
4
H2-antagonists and carmustine.H2拮抗剂与卡莫司汀。
J Cancer Res Clin Oncol. 1989;115(1):41-6. doi: 10.1007/BF00391598.
5
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
6
A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.一种新型浓缩全氟化学乳剂及含二氧化碳的氧气吸入作为抗肿瘤烷化剂治疗的辅助手段。
J Cancer Res Clin Oncol. 1992;118(7):509-14. doi: 10.1007/BF01225265.
7
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
8
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
6-Methylguanine and 6-methylguanosine inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line but not in other xeroderma pigmentosum and normal human fibroblast strains after treatment with 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea.在用1-(2-氯乙基)-1-亚硝基-3-(2-羟乙基)脲处理后,6-甲基鸟嘌呤和6-甲基鸟苷抑制恶性色素沉着性干皮病细胞系的集落形成能力,但不抑制其他色素沉着性干皮病和正常人成纤维细胞株的集落形成能力。
J Cancer Res Clin Oncol. 1987;113(1):67-72. doi: 10.1007/BF00389969.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
DNA adducts and DNA damage by antineoplastic and carcinogenic N-nitrosocompounds.抗肿瘤和致癌性N-亚硝基化合物导致的DNA加合物与DNA损伤
J Cancer Res Clin Oncol. 1986;112(3):196-204. doi: 10.1007/BF00395912.

本文引用的文献

1
The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.在接受四种氯乙基亚硝基脲治疗的小鼠中,骨髓中DNA链间交联的水平与骨髓抑制的程度平行。
J Cancer Res Clin Oncol. 1984;108(1):141-7. doi: 10.1007/BF00390986.
2
1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
Adv Cancer Res. 1972;16:273-332. doi: 10.1016/s0065-230x(08)60343-7.
3
Chemistry and structure-activity studies of the nitrosoureas.亚硝基脲类的化学与构效关系研究
Cancer Treat Rep. 1976 Jun;60(6):651-64.
4
DNA-protein cross-linking and DNA interstrand cross-linking by haloethylnitrosoureas in L1210 cells.卤代乙基亚硝基脲在L1210细胞中导致的DNA-蛋白质交联和DNA链间交联
Cancer Res. 1978 Oct;38(10):3197-203.
5
Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential.抗癌剂1,3-双(2-氯乙基)-1-亚硝基脲(卡莫司汀)的一些新同系物。双功能类似物和水溶性衍生物的合成及其化疗潜力的初步评估。
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976 Aug 30;86(3):279-86. doi: 10.1007/BF00286946.

单次及重复给予卡莫司汀(BCNU)和洛莫司汀(HECNU)后小鼠骨髓中DNA损伤与干细胞抑制之间的关系

Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU.

作者信息

Berger M R, Henne T, Bedford P

出版信息

J Cancer Res Clin Oncol. 1985;110(3):185-90. doi: 10.1007/BF00399271.

DOI:10.1007/BF00399271
PMID:4077917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12252801/
Abstract

The effects of dose and schedule of administration of either 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea (HECNU) were compared in terms of induction of DNA damage in the bone marrow of male C6B3F1 mice or in the inhibition of two stem cell lines contained therein. At equimolar doses HECNU induced a 3- to 40-fold deeper nadir of proliferation of both stem cell lines compared to BCNU, but subsequently a 2- to 30-fold quicker recovery of these lines was observed. An enhancement of myelotoxicity was only found following injections with intervals of 1 week. Myelosuppression was almost twice as great, when six instead of three weekly injections of 50 mumol/kg were given. When, however, sufficient time was allowed for recovery, doubling the number of significantly larger doses of drug was tolerated at the level of the bone marrow stem cell. The maximum inhibition of pluripotent- and granulocyte-committed stem cells following HECNU was paralleled by higher amounts of DNA-DNA interstrand crosslinks in the entire bone marrow compared to BCNU. During the initial stages, the degree of myelosuppression did, to some extent, parallel the number of DNA-DNA interstrand crosslinks induced in the bone marrow as a whole, but this relation was lost after the initial period.

摘要

比较了1,3 - 双(2 - 氯乙基)-1 - 亚硝基脲(BCNU)或1 - (2 - 羟乙基)-3 - (2 - 氯乙基)-3 - 亚硝基脲(HECNU)的剂量和给药方案对雄性C6B3F1小鼠骨髓中DNA损伤的诱导作用,或对其中所含两种干细胞系的抑制作用。在等摩尔剂量下,与BCNU相比,HECNU诱导两种干细胞系增殖的最低点深3至40倍,但随后观察到这些细胞系的恢复速度快2至30倍。仅在间隔1周注射后才发现骨髓毒性增强。当每周注射6次而非3次50 μmol/kg时,骨髓抑制几乎增加了一倍。然而,当给予足够的恢复时间时,在骨髓干细胞水平上可以耐受将剂量显著增加一倍。与BCNU相比,HECNU后多能和粒细胞定向干细胞的最大抑制与整个骨髓中更高量的DNA - DNA链间交联平行。在初始阶段,骨髓抑制程度在一定程度上与整个骨髓中诱导的DNA - DNA链间交联数量平行,但在初始期后这种关系消失。